IfPA’s Patient Access Policy Blog

New Law Recognizes Family Caregivers

An estimated 65 million family caregivers help their elderly, disabled or ill loved ones continue to live at home – driving them to appointments and

Read More

CAR-T Cancer Drugs Get Nod of Approval from ICER

Innovative but expensive CAR-T therapies for cancer are worth their price, announced the Institute for Clinical and Economic Review recently.  The organization is the self-appointed

Read More

Medicaid Rx Coverage Schemes Threaten Patient Access

Cash-strapped states are exploring a controversial new way to cut Medicaid expenses: limiting which drugs their beneficiaries can access.   In Massachusetts, officials requested a

Read More

Medicare Patients Could Gain Access to Critical Diagnostic Test

Nearly 1.7 million Americans learned they had cancer in 2017. Most of these patients began traditional treatments like chemotherapy, radiation and surgery. Yet for many,

Read More

Vaccine-preventable Diseases Plague Unprotected Americans

Winter weather blasted much of the nation last week, but it’s not just the common cold that Americans are fighting. Many regions, regardless of temperature,

Read More

Racial Disparity Mars Infants’ Access to Donor Milk

All mothers want to give their babies a stronger immune system, reduce their risk of SIDS and lower their rate of respiratory infections. But a recent

Read More

2017 in Review: 7 Trends in Patient Access

  As 2017 draws to a close, let’s take a look back at the highlights in patient access this year. 1. Breakthrough cardiovascular medicine eludes

Read More

Putting a Price on Migraine Prevention

What are new drugs to prevent migraine worth?  The question is driving a forthcoming report from cost-effectiveness giant the Institute for Clinical and Economic Review

Read More

A Victory for NICU Patient Safety

Hospital NICUs are getting an early Christmas present: the ability to opt out on tubing that could put their newborn patients at risk. The Joint

Read More

Revamped EudraVigilance System Could Improve Drug Safety Reporting

Preventable drug safety issues caused nearly 200,000 deaths across the European Union in 2017.  Now the European Medicines Agency is working to address that statistic

Read More
Back to Top